Hubert Schrezenmeier

26.0k citations

381 papers · 16.1k indexed · 2 hit papers · h-index 66

Impact in

Hematology top 0.05%
- Hematopoietic Stem Cell Transplantation
- Blood groups and transfusion
- Platelet Disorders and Treatments
Genetics top 0.1%
- Mesenchymal stem cell research

Papers in

Hematology 181
- Hematopoietic Stem Cell Transplantation 81
- Blood groups and transfusion 65
- Platelet Disorders and Treatments 25
Genetics 94
- Mesenchymal stem cell research 44

Co-authors: Bernhard Fleischer Markus Rojewski Gèrard Socié Antonio M. Risitano Peter Hillmen Robert A. Brodsky Jakob Passweg H. Heimpel
Journals: Blood (74 papers)Annals of Hematology (17 papers)The Journal of Immunology (14 papers)British Journal of Haematology (13 papers)Transfusion (12 papers)
Partner nations: Germany United States France

In The Last Decade

Hubert Schrezenmeier

367 papers receiving 15.7k citations

Hit Papers

align trajectories log scale

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies 2021 · 563 citations

Peers

Countries citing papers authored by Hubert Schrezenmeier

Since Specialization

Citations

This map shows the geographic impact of Hubert Schrezenmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hubert Schrezenmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hubert Schrezenmeier more than expected).

Fields of papers citing papers by Hubert Schrezenmeier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hubert Schrezenmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hubert Schrezenmeier. The network helps show where Hubert Schrezenmeier may publish in the future.

Co-authors

The 25 scholars most cited alongside Hubert Schrezenmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hubert Schrezenmeier Line = papers co-authored together Hubert Schrezenmeier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Senescent erythrocytes as a trigger of complement activation and implications for breakthrough haemolysis in paroxysmal nocturnal haemoglobinuria patients Immunobiology ·Sümeyye Erdemci-Evin, Britta Höchsmann, Hiba Ghaboosh, Marco Mannes, Hubert Schrezenmeier, Christoph Q. Schmidt	2025	0
2	Bone Augmentation of Atrophic Alveolar Ridges Using a Synthetic Bone Substitute With Mesenchymal Stem Cells: A Randomized, Controlled Clinical Trial Clinical Oral Implants Research ·Mariano Sanz, Cecilie Gjerde, Bjørn Tore Gjertsen, Alberto Ortiz‐Vigón, Nerea Sánchez, Alain Hoornaert, Jordi Caballé‐Serrano, Maria Giralt‐Hernando, Frédérick Gaultier, Nicoleta Reinald, Else Marie Pinholt, Markus Rojewski, Hélène Rouard, Nathalie Chevallier, Samih Mohamed‐Ahmed, Xie‐Qi Shi, Tiejun Shi, Hubert Schrezenmeier, Pierre Layrolle, Kamal Mustafa	2025	1
3	The complement model disease paroxysmal nocturnal hemoglobinuria European Journal of Immunology ·Christoph Q. Schmidt, Britta Höchsmann, Hubert Schrezenmeier	2024	4
4	Ravulizumab in Pregnant Women with Paroxysmal Nocturnal Hemoglobinuria (PNH) - Favourable Experience from a Retrospective Case Series Blood ·Britta Hoechsmann, Wilhelm Leopold, A. Schneider, Sixten Koerper, Ursula Kalhammer, Hubert Schrezenmeier	2024	2
5	Immunotherapeutic Potential of Mutated NPM1 for the Treatment of Acute Myeloid Leukemia Cancers ·Jochen Greiner, Eithar Mohamed, Daniel Fletcher, Patrick J. Schuler, Hubert Schrezenmeier, Marlies Götz, Barbara‐ann Guinn	2024	2
6	Danicopan As Add-on Therapy to Ravulizumab or Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Long-Term Patient-Reported Outcomes from the Phase 3 ALPHA Trial Blood ·Caroline Piatek, Jong Wook Lee, Morag Griffin, J Nishimura, Christopher J. Patriquin, Hubert Schrezenmeier, Wilma Barcellini, Jamile M. Shammo, Anna Gayà, Mohammed H. Mahdi, Peng Liu, Karl-Johan Myrén, Andrew Messali, Flore Sicre de Fontbrune, Jens Panse, Austin Kulasekararaj	2024	1
7	Immune Plasma for the Treatment of COVID-19: Lessons Learned so far Hämostaseologie ·Hubert Schrezenmeier, Simone Hoffmann, Henrike Hofmann, Thomas Appl, Bernd Jahrsdörfer, Erhard Seifried, Sixten Körper	2023	2
8	Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria Annals of Hematology ·Hubert Schrezenmeier, Austin Kulasekararaj, Lindsay Mitchell, Régis Peffault de Latour, Timothy Devos, Shinichiro Okamoto, Richard A. Wells, Evan Popoff, Antoinette Cheung, Alice Wang, Ioannis Tomazos, Yogesh Patel, Jong Wook Lee	2023	6
9	Complement and platelets: prothrombotic cell activation requires membrane attack complex–induced release of danger signals Blood Advances ·Marco Mannes, Veronika Pechtl, Susanne Häfner, Arthur Dopler, Oskar Eriksson, Vivek Anand Manivel, Lisa Wohlgemuth, David Alexander Christian Messerer, Hubert Schrezenmeier, Kristina Nilsson Ekdahl, Bo Nilsson, Eva‐Maria Jacobsen, Manfred Hoenig, Markus Huber‐Lang, Christian Braun, Christoph Q. Schmidt	2023	18
10	Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation The Journal of Immunology ·Markus Anliker, Daniela Drees, Lorin Loacker, Susanne Häfner, Andrea Griesmacher, Gregor Hoermann, Vilmos Fux, Harald Schennach, Paul Hörtnagl, Arthur Dopler, Stefan Schmidt, Rosa Bellmann‐Weiler, Günter Weiß, Astrid Marx‐Hofmann, Sixten Körper, Britta Höchsmann, Hubert Schrezenmeier, Christoph Q. Schmidt	2022	3
11	B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Journal of the American Society of Nephrology ·Eva Schrezenmeier, Héctor Rincón-Arévalo, Ana‐Luisa Stefanski, Alexander Potekhin, Henriette Staub-Hohenbleicher, Mira Choi, Friederike Bachmann, Vanessa Proβ, Charlotte Hammett, Hubert Schrezenmeier, Carolin Ludwig, Bernd Jahrsdörfer, Andreia C. Lino, Kai‐Uwe Eckardt, Katja Kotsch, Thomas Dörner, Klemens Budde, Arne Sattler, Fabian Halleck	2021	61
12	Altered increase in STAT1 expression and phosphorylation in severe COVID‐19 European Journal of Immunology ·Héctor Rincón-Arévalo, Arman Aue, Jacob Ritter, Franziska Szelinski, Dmytro Khadzhynov, Daniel Zickler, Ana‐Luisa Stefanski, Andreia C. Lino, Sixten Körper, Kai‐Uwe Eckardt, Hubert Schrezenmeier, Thomas Dörner, Eva Schrezenmeier	2021	35
13	Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity Blood ·Marco Mannes, Arthur Dopler, Oliver Zolk, Sophia J. Lang, Rebecca Halbgebauer, Britta Höchsmann, Arne Skerra, Christian Braun, Markus Huber‐Lang, Hubert Schrezenmeier, Christoph Q. Schmidt	2020	65
14	First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001‐2012 American Journal of Hematology ·Andrea Bacigalupo, Rosi Oneto, Hubert Schrezenmeier, Britta Höchsmann, Carlo Dufour, Seiji Kojima, Xiaofan Zhu, Xiaojuan Chen, Surapol Issaragrisil, Suporn Chuncharunee, Dae Chul Jeong, Sabrina Giammarco, Maria Teresa Van Lint, Yizhou Zheng, Carlos Vallejo	2018	34
15	Interleukin 21–Induced Granzyme B–Expressing B Cells Infiltrate Tumors and Regulate T Cells Cancer Research ·Stefanie Lindner, Karen Dahlke, Kai Sontheimer, Magdalena Hagn, Christof Kaltenmeier, Thomas F.E. Barth, Thamara Beyer, Frank Reister, Dorit Fabricius, Ramin Lotfi, Oleg Lunov, G. Ulrich Nienhaus, Thomas Simmet, R. Kreienberg, Peter Möller, Hubert Schrezenmeier, Bernd Jahrsdörfer	2013	273
16	Recommendations for the diagnosis of paroxysmal nocturnal hemoglobinuria: a German-Austrian Consensus1) LaboratoriumsMedizin ·Hubert Schrezenmeier, Peter Bettelheim, Jens Panse, Jörg Schubert, Britta Höchsmann, Alexander Röth, Thomas Nebe	2012	2
17	Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components Cytotherapy ·Natalie Fekete, Mélanie Gadelorge, Daniel E. Fürst, Caroline Maurer, Julia Dausend, Sandrine Fleury‐Cappellesso, Volker Mailänder, Ramin Lotfi, Anita Ignatius, Luc Sensebé, Philippe Bourin, Hubert Schrezenmeier, Markus Rojewski	2012	241
18	Human B cells differentiate into granzyme B‐secreting cytotoxic B lymphocytes upon incomplete T‐cell help Immunology and Cell Biology ·Magdalena Hagn, Kai Sontheimer, Karen Dahlke, Sabine Brueggemann, Christof Kaltenmeier, Thamara Beyer, Stefanie Hofmann, Oleg Lunov, Thomas F.E. Barth, Dorit Fabricius, Kyrylo Tron, G. Ulrich Nienhaus, Thomas Simmet, Hubert Schrezenmeier, Bernd Jahrsdörfer	2011	82
19	Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria Blood ·Robert A. Brodsky, Neal S. Young, Elisabetta Antonioli, Antonio M. Risitano, Hubert Schrezenmeier, Jörg Schubert, Anna Gayà, Luke Coyle, Carlos de Castro Lozano, Chieh‐Lin Fu, Jaroslaw P. Maciejewski, Monica Bessler, Henk-André Kroon, Russell P. Rother, Peter Hillmen	2007	457
20	Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT) Blood ·Gèrard Socié, Jean–Yves Mary, Hubert Schrezenmeier, Judith Marsh, Andrea Bacigalupo, Anna Locasciulli, Monica Fuehrer, Albert N. Békássy, André Tichelli, Jakob Passweg	2006	77

About Hubert Schrezenmeier

Hubert Schrezenmeier is a scholar working on Hematology, Genetics, Immunology, Nephrology and Transplantation, having authored 381 papers that have together received 16.1k indexed citations. Recurring topics across this work include Complement system in diseases (100 papers), Hematopoietic Stem Cell Transplantation (81 papers), Blood groups and transfusion (65 papers), Renal Diseases and Glomerulopathies (51 papers), Mesenchymal stem cell research (44 papers), T-cell and B-cell Immunology (38 papers), Immune Cell Function and Interaction (37 papers) and Platelet Disorders and Treatments (25 papers). The work is most often cited by research in Hematology (6.1k citations), Genetics (3.8k citations), Immunology (6.7k citations), Nephrology (2.2k citations) and Transplantation (731 citations). Hubert Schrezenmeier has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Bernhard Fleischer, Markus Rojewski, Gèrard Socié, Antonio M. Risitano, Peter Hillmen, Robert A. Brodsky, Jakob Passweg, H. Heimpel, Britta Höchsmann and Jeff Szer. Their work appears in journals such as Blood, Annals of Hematology, The Journal of Immunology, British Journal of Haematology and Transfusion.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact